drugset / Trial / NCT01199198
Tolvaptan in Hyponatremic Cancer Patients
Phase 4
Completed
52 enrolled
M.D. Anderson Cancer Center
Otsuka Pharmaceutical Development & Commercialization, Inc. · collab
RandomizedSingle-groupSingle-blindTreatment
Summary
The goal of this clinical research study is to learn if tolvaptan can help raise salt (sodium) levels in the cancer patients' blood by removing extra body water as urine.
Timeline
- Start
- 2011-05
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tolvaptan | Small molecule | 15 mg | Oral |
Indications
No indication recorded.